LAZ May 2024 38.000 call
| Previous close | 1.4600 |
| Open | 1.4600 |
| Bid | 0.7000 |
| Ask | 2.2000 |
| Strike | 38.00 |
| Expiry date | 2024-05-17 |
| Day's range | 1.4600 - 1.4600 |
| Contract range | N/A |
| Volume | |
| Open interest | 28 |
Business WireLazard Reports April 2024 Assets Under Management
NEW YORK, May 10, 2024--Lazard, Inc. (NYSE: LAZ) reported today that its preliminary assets under management ("AUM") as of April 30, 2024 totaled approximately $240.8 billion. The month’s AUM included market depreciation of $4.4 billion, net outflows of $3.6 billion and foreign exchange depreciation of $1.6 billion.
ReutersLazard hires veteran healthcare dealmaker Colocci as vice chairman
Investment bank Lazard Ltd has appointed veteran healthcare dealmaker Michele Colocci as vice chairman and managing director, aiming to boost the growth of its healthcare advisory, according to a company announcement. Colocci, former chairman of mergers and acquisitions at Morgan Stanley, where he also held positions as global co-head of healthcare investment banking and deputy head of investment banking for Europe, is set to join the firm in June. In his new role, Colocci will be part of Lazard's healthcare franchise, led by David Gluckman and overseen in Europe by Jean-Louis Girodolle and Cyrus Kapadia.
Business WireLazard Welcomes Michele Colocci as Vice Chairman, Investment Banking and Managing Director, Healthcare
NEW YORK, May 09, 2024--Lazard, Inc. (NYSE: LAZ) today announced Michele Colocci is joining the firm on 3rd June 2024 as Vice Chairman, Investment Banking and Managing Director, Healthcare. Based in London, Mr. Colocci’s appointment accelerates the growth of Lazard’s best-in-class global healthcare franchise, led by David Gluckman, and further reinforces its leading position in Europe, which is headed by Jean-Louis Girodolle and Cyrus Kapadia.
